ArticleIn vivo (Athens, Greece)
RXRG as a Novel Biomarker and its Correlation With Immune Infiltration in Thyroid Carcinoma.
Article in In vivo (Athens, Greece). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- RXR Gamma Enables Oligodendrocyte Differentiation by Suppressing Sonic Hedgehog Signaling.Glia · 2026Article
- Precision Thyroid Oncology: A Review of Multi-Omics Biomarkers and Spatiotemporal Technologies.International journal of general medicine · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND/
aimThyroid carcinoma (THCA) is the most prevalent type of endocrine cancer. Retinoid X Receptor Gamma (RXRG) encodes a member of the retinoid X receptor (RXR) family of nuclear receptors that are involved in mediating the antiproliferative effects of retinoic acid (RA). However, the role of RXRG in THCA remains unclear. MATERIALS AND
methodsMultiple public databases were utilized to investigate RXRG expression in THCA and its role in THCA prognosis, analyze the RXRG co-expressed genes and protein-protein interaction (PPI) networks, as well as to analyze the immune cell infiltration in THCA using enrichment analysis and the association of RXRG expression with immune cell infiltration.
resultsThe expression of RXRG is higher in THCA tissues than in normal thyroid tissues. In THCA, a reduced expression of RXRG is associated with poor prognosis. Both the pathological stage and RXRG expression are independent risk factors for the overall survival (OS) of THCA patients. RXRG is mainly associated with signaling pathways such as cytokine-cytokine receptor interaction, chemokine signaling pathway, interleukin signaling, and interleukin-18 signaling pathway, all of which may be related to immunity. Finally, it was found that the expression of RXRG is associated with the infiltration of various immune cells and may affect the prognosis of patients through changes in the immune environment.
conclusionRXRG has a significant impact on the tumor microenvironment (TME) of THCA, potentially serving as a valuable biomarker for the diagnosis and treatment of this malignancy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.